Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease

被引:343
|
作者
Savelieff, MG
Lee, S
Liu, YZ
Lim, MH [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家科学基金会;
关键词
A-BETA; OXIDATIVE STRESS; STRUCTURAL-CHARACTERIZATION; NEUROFIBRILLARY TANGLES; IN-VIVO; PROTEIN; AGGREGATION; PEPTIDE; BINDING; PHOSPHORYLATION;
D O I
10.1021/cb400080f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding and metal ion dyshomeostasis are believed to underlie numerous neurodegenerative diseases, including Alzheimer's disease (AD). The pathological hallmark of AD is accumulation of misfolded amyloid-beta (A beta) peptides and hyperphosphorylated tau (ptau) proteins in the brain. Since AD etiology remains unclear, several hypotheses have emerged to elucidate its pathological pathways. The amyloid cascade hypothesis, a leading hypothesis for AD development, advocates A beta as the principal culprit. Additionally, evidence suggests that tau may contribute to AD pathology. A beta and tau have also been shown to impact each other's pathology either directly or indirectly. Furthermore, metal ion dyshomeostasis is associated with these misfolded proteins. Metal interactions with A beta and tau/ptau also influences their aggregation properties and neurotoxicity. Herein, we present current understanding on the roles of A beta, tau, and metal ions, placing equal emphasis on each of these proposed features, as well as their inter-relationships in AD pathogenesis.
引用
收藏
页码:856 / 865
页数:10
相关论文
共 50 条
  • [21] Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
    João Pedro Ferrari-Souza
    Pâmela C. L. Ferreira
    Bruna Bellaver
    Cécile Tissot
    Yi-Ting Wang
    Douglas T. Leffa
    Wagner S. Brum
    Andréa L. Benedet
    Nicholas J. Ashton
    Marco Antônio De Bastiani
    Andréia Rocha
    Joseph Therriault
    Firoza Z. Lussier
    Mira Chamoun
    Stijn Servaes
    Gleb Bezgin
    Min Su Kang
    Jenna Stevenson
    Nesrine Rahmouni
    Vanessa Pallen
    Nina Margherita Poltronetti
    William E. Klunk
    Dana L. Tudorascu
    Ann D. Cohen
    Victor L. Villemagne
    Serge Gauthier
    Kaj Blennow
    Henrik Zetterberg
    Diogo O. Souza
    Thomas K. Karikari
    Eduardo R. Zimmer
    Pedro Rosa-Neto
    Tharick A. Pascoal
    Molecular Psychiatry, 2022, 27 : 4781 - 4789
  • [22] Application of Yeast to Study the Tau and Amyloid-β Abnormalities of Alzheimer's Disease
    Porzoor, Afsaneh
    Macreadie, Ian G.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (02) : 217 - 225
  • [23] Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
    Lars M. Ittner
    Jürgen Götz
    Nature Reviews Neuroscience, 2011, 12 : 67 - 72
  • [24] Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
    Ittner, Lars M.
    Goetz, Juergen
    NATURE REVIEWS NEUROSCIENCE, 2011, 12 (02) : 67 - 72
  • [25] Pyroglutamylated amyloid-β correlates with hyperphosphorylated tau and severity of Alzheimer's disease
    Walker, L.
    Mandler, M.
    Santic, R.
    Hanson, P.
    Upadhaya, A. R.
    Colloby, S. J.
    Morris, C. M.
    Thal, D. R.
    Thomas, A. J.
    Schneeberger, A.
    Attems, J.
    BRAIN PATHOLOGY, 2014, 24 : 42 - 42
  • [26] Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease
    Ferrari-Souza, Joao Pedro
    Ferreira, Pamela C. L.
    Bellaver, Bruna
    Tissot, Cecile
    Wang, Yi-Ting
    Leffa, Douglas T.
    Brum, Wagner S.
    Benedet, Andrea L.
    Ashton, Nicholas J.
    De Bastiani, Marco Antonio
    Rocha, Andreia
    Therriault, Joseph
    Lussier, Firoza Z.
    Chamoun, Mira
    Servaes, Stijn
    Bezgin, Gleb
    Kang, Min Su
    Stevenson, Jenna
    Rahmouni, Nesrine
    Pallen, Vanessa
    Poltronetti, Nina Margherita
    Klunk, William E.
    Tudorascu, Dana L.
    Cohen, Ann D.
    Villemagne, Victor L.
    Gauthier, Serge
    Blennow, Kaj
    Zetterberg, Henrik
    Souza, Diogo O.
    Karikari, Thomas K.
    Zimmer, Eduardo R.
    Rosa-Neto, Pedro
    Pascoal, Tharick A.
    MOLECULAR PSYCHIATRY, 2022, 27 (11) : 4781 - 4789
  • [27] Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's disease
    Ower, Alison K.
    Hadjichrysanthou, Christoforos
    Gras, Luuk
    Goudsmit, Jaap
    Anderson, Roy M.
    de Wolf, Frank
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2018, 33 (07) : 657 - 666
  • [28] New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease
    Zhang, Feng
    Zhong, Ru-jia
    Cheng, Cheng
    Li, Song
    Le, Wei-dong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (09) : 1382 - 1389
  • [29] Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease
    Torres, Angie K.
    Jara, Claudia
    Park-Kang, Han S.
    Polanco, Catalina M.
    Tapia, Diego
    Alarcon, Fabian
    de la Pena, Adely
    Llanquinao, Jesus
    Vargas-Mardones, Gabriela
    Indo, Javiera A.
    Inestrosa, Nibaldo C.
    Tapia-Rojas, Cheril
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 84 (04) : 1391 - 1414
  • [30] Pathogenesis of Alzheimer's Disease: Role of Amyloid-β and Hyperphosphorylated Tau Protein
    Sajjad, Rabia
    Arif, Rawaba
    Shah, A. A.
    Manzoor, I.
    Mustafa, G.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (04) : 581 - 591